Trump's win shows us who we really are: This article by professor Aaron W. Hughey is one of the most powerful and accurate post-election indictments of America you'll ever read. 😳👇
As I spend time soul searching, I find strength and calm in the many people over the years who have gently, silently and with great resolve - put their hand on my shoulder and said “you can.”
We’re thrilled to announce that Anji and Population Health Partners have entered into a strategic collaboration to accelerate development of our two lead clinical assets ANJ900 (delayed-release #metformin) and ANJ908 (pradigastat).Read more here https://t.co/jMlcdXC4c9 #T2D#CKD
✨Major upgrades are currently being made to our Camel Athletics facilities✨
⚪️ New locker rooms, coaching offices at Dayton Arena in progress
⚪️ Improved sound system at Silfen Field
⚪️ Paved road and sidewalks down to the waterfront
Still more to come 🐪!
#ChronicConstipation affects approximately 14% of the adult population in the U.S. The most common types are chronic idiopathic constipation (CIC) and irritable bowel syndrome-associated constipation (#IBS-C). Learn more: https://t.co/zHnPIq3e2p #GITwitter
Accelerated approval is an incredibly important tool - for #patients. It is critical though that #biotech continues to seek clinical benefit and not solely a fast endpoint. @US_FDA
“I am a fan of accelerated approvals,” says @US_FDA’s Robert Califf.
Today, #BIO2022 closes out with a timely and critical discussion on the importance of accelerated approvals in bringing life-changing innovations to patients. Hosted by @DrMichelleBIO.
@AnjiPharmaUS Welcome Chloe! Should be an exciting next few years at Anji....with our #oncology portfolio kicking off several new trials and our continued work in #diabetes and other therapeutic areas.
We are proud to have made great progress in the global development of ANJ900 so that we may bring new treatment options to type 2 diabetes patients with chronic kidney disease. Connect with us at #ADA2022 to learn more. https://t.co/2eD8FDOJIw #Metformin#diabetes